Purple Biotech Ltd. announced a significant study revealing that their drug NT219, combined with 5-fluorouracil (5-FU), effectively inhibits colorectal cancer brain metastasis by targeting the IRS2 ...
Study reveals the drug, 5-fluorouracil, acts differently in different types of cancer — a finding that could help researchers design better drug combinations. Since the 1950s, a chemotherapy drug ...
PURPOSE: To compare protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin (MMC) in patients with advanced pancreatic cancer in a multicenter, prospectively randomized study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results